B

Bay Area Retina Associates | Walnut Creek, CA

Research site
(Unclaimed)
Location
365 Lennon Lane, Suite 250, Walnut Creek, California, United States of America
Site insights

Top conditions

Macular Degeneration (22 trials)

Macular Edema (19 trials)

Edema (17 trials)

Geographic Atrophy (9 trials)

Atrophy (8 trials)

Top treatments

Ranibizumab
Bevacizumab
RBM-007
RO7200220
Pegcetacoplan
Vamikibart
dexamethasone
Lampalizumab
APL-2
-Ranibizumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

8 of 45
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.

Enrolling
Geographic Atrophy
Drug: Triamcinolone
Other: Sham Procedure

Study BP43464 is a phase II, multicenter, randomized, double-masked active comparator-controlled study designed to assess the efficacy, safety, toler...

Active, not recruiting
Diabetic Macular Edema
Drug: Vamikibart
Drug: Ranibizumab

Study BP43445 is a phase II, multicenter, randomized, double-masked, active comparator-controlled study to investigate the efficacy, safety, tolerabi...

Active, not recruiting
Diabetic Macular Edema
Drug: Ranibizumab
Drug: Vamikibart

This is a phase 3, open-label, multicenter, extension study to evaluate the long-term safety and efficacy of pegcetacoplan (APL-2) in subjects with g...

Active, not recruiting
Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: PEGCETACOPLAN (APL-2)

The goal of this clinical trial is to assess the efficacy and safety of multiple doses of foselutoclax (UBX1325) in patients with Diabetic Macular Ed...

Enrolling
Edema
Diabetic Macular Edema
Drug: foselutoclax
Drug: Aflibercept

Evaluate the safety and efficacy of transpalpebral microcurrent stimulation (MCS) therapy for patients with nonexudative (dry) age-related macular de...

Enrolling
Age-Related Macular Degeneration
Nonexudative Age-related Macular Degeneration
Device: i-Lumen(TM) AMD Sham
Device: i-Lumen(TM) AMD

The purpose of this Phase 1 study is comprised of multiple ascending-dose component (Part 1) and high concentration component (Part 2) to evaluate th...

Enrolling
Neovascular Age-related Macular Degeneration
Biological: AM712(ASKG712)

The primary objective of this study is to compare the efficacy of antecedent intravitreal anti-vascular endothelial growth factor therapy vs. Ozurdex...

Enrolling
Cataract
Diabetic Macular Edema
Drug: Aflibercept
Drug: Bevacizumab

Trial sponsors

Jaeb Center for Health Research logo

Jaeb Center for Health Research (11 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems